| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440439 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
Rechallenge with BRAFi ± MEKi results in a clinically meaningful benefit and should be considered for selected patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sara Valpione, Matteo S. Carlino, Johanna Mangana, Meghan J. Mooradian, Grant McArthur, Dirk Schadendorf, Axel Hauschild, Alexander M. Menzies, Ana Arance, Paolo A. Ascierto, AnnaMaria Di Giacomo, Francesco de Rosa, James Larkin, John J. Park,